Scarica l'app Stockscreener
4.35
50.34%
-4.41
Dopo l'orario di chiusura:
4.55
0.20
+4.60%
Precedente Chiudi:
$8.76
Aprire:
$4.4
Volume 24 ore:
597.86K
Relative Volume:
0.94
Capitalizzazione di mercato:
$3.06M
Reddito:
-
Utile/perdita netta:
$-9.60M
Rapporto P/E:
-1.3766
EPS:
-3.16
Flusso di cassa netto:
$-8.96M
1 W Prestazione:
-51.88%
1M Prestazione:
-56.19%
6M Prestazione:
-29.95%
1 anno Prestazione:
-41.06%
Intervallo 1D:
$4.20
$4.66
Intervallo di 1 settimana:
$4.20
$9.38
Portata 52W:
$4.20
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Nome
Artelo Biosciences Inc
Settore
Industria
Telefono
858-925-7049
Indirizzo
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Confronta ARTL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
4.35 | 11.96M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2021-02-12 | Iniziato | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Borsa (ARTL) Ultime notizie
Does Artelo Biosciences Inc. offer margin of safetyJuly 2025 Momentum & Consistent Return Strategy Ideas - khodrobank.com
Artelo Biosciences announces proposed underwritten public offering - MarketScreener
Artelo Biosciences launches public offering of common stock - Investing.com
Artelo Biosciences reports interim Phase 2 data for cancer cachexia treatment - Investing.com
Artelo Biosciences launches public offering; shares down 10% - MSN
Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewswire
Clinical-Stage Pharma Artelo Biosciences Launches New Public Stock Offering via R.F. Lafferty - Stock Titan
Artelo Biosciences Drug Helps Cancer Patients Regain Weight, Eyes Licensing Deal - Benzinga
Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results - The Manila Times
Cancer Wasting Treatment Breakthrough: Artelo's ART27.13 Shows Promise in Phase 2 Trial for 80% of Cancer Patients - Stock Titan
Artelo Biosciences Reports Encouraging Interim Results for ART27.13 in Phase 2 Cancer Appetite Recovery Study, Supporting Weight Gain and Activity Improvements in Cancer Patients - Quiver Quantitative
Artelo Biosciences Announces Positive Interim Phase 2 CAReS - GlobeNewswire
18.5% Maximum Weight Gain: Artelo's Cancer Cachexia Drug Shows Breakthrough Results in Phase 2 Trial - Stock Titan
How to manage a losing position in Artelo Biosciences Inc.2025 Earnings Impact & Fast Moving Trade Plans - Newser
Price action breakdown for Artelo Biosciences Inc.Buy Signal & Momentum Based Trading Signals - Newser
Sentiment analysis tools applied to Artelo Biosciences Inc.Options Play & High Win Rate Trade Alerts - Newser
Will Artelo Biosciences Inc. continue its uptrend2025 Top Decliners & AI Forecasted Entry and Exit Points - Newser
Quantitative breakdown of Artelo Biosciences Inc. recent move2025 Market Sentiment & Expert Verified Movement Alerts - Newser
Can Artelo Biosciences Inc. rally from current levelsTrade Risk Report & Fast Exit/Entry Strategy Plans - Newser
Published on: 2025-09-02 13:42:59 - Newser
Artelo Biosciences stock triggers KDJ Golden Cross, bullish Marubozu formation. - AInvest
What’s the fair value of Artelo Biosciences Inc. stock2025 Geopolitical Influence & Technical Entry and Exit Tips - khodrobank.com
Leading vs lagging indicators on Artelo Biosciences Inc. performanceBond Market & Reliable Price Breakout Signals - Newser
Is Artelo Biosciences Inc. being accumulated by smart money2025 Market WrapUp & Risk Controlled Swing Alerts - khodrobank.com
Best data tools to analyze Artelo Biosciences Inc. stockAnalyst Upgrade & Weekly High Conviction Ideas - Newser
Custom strategy builders for tracking Artelo Biosciences Inc.Portfolio Risk Summary & Long-Term Safe Investment Plans - Newser
Institutional scanner results for Artelo Biosciences Inc.2025 Top Decliners & Weekly High Potential Stock Alerts - Newser
Tools to assess Artelo Biosciences Inc.’s risk profileBuy Signal & Growth Oriented Trade Recommendations - Newser
Artelo Biosciences Inc. stock trend outlook and recovery pathWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser
Will Artelo Biosciences Inc. benefit from macro trendsTrade Analysis Report & Expert Curated Trade Setup Alerts - Newser
Ranking Artelo Biosciences Inc. among high performing stocks via toolsBond Market & Fast Entry Momentum Trade Alerts - Newser
Can Artelo Biosciences Inc. sustain its profitabilityWeekly Investment Recap & Capital Protection Trading Alerts - khodrobank.com
How does Artelo Biosciences Inc. compare to its peersPortfolio Update Summary & Weekly Stock Performance Updates - khodrobank.com
Can Traders Expect Breakout From Artelo Biosciences Inc. This WeekWeekly Trade Report & High Conviction Trade Alerts - beatles.ru
Does Artelo Biosciences Inc. stock benefit from AI growth2025 Sector Review & Fast Momentum Stock Entry Tips - khodrobank.com
How to use a screener to detect Artelo Biosciences Inc. breakouts2025 EndofYear Setup & Long Hold Capital Preservation Tips - Newser
Predicting Artelo Biosciences Inc. trend using moving averagesNew Guidance & Low Risk Entry Point Tips - Newser
Is a relief rally coming for Artelo Biosciences Inc. holders2025 Momentum Check & Weekly Return Optimization Alerts - Newser
What Fibonacci levels say about Artelo Biosciences Inc. reboundJuly 2025 Volume & Fast Moving Market Watchlists - Newser
Artelo Biosciences Inc. Charts Flash Early Recovery Signals getLinesFromResByArray error: size == 0 - newsyoung.net
Is Artelo Biosciences Inc. forming a reversal patternTrade Performance Summary & AI Forecast for Swing Trade Picks - Newser
Using economic indicators to assess Artelo Biosciences Inc. potentialTrade Analysis Report & Expert Approved Momentum Ideas - Newser
How to interpret RSI for Artelo Biosciences Inc. stockQuarterly Trade Review & Safe Entry Point Identification - Newser
Artelo Biosciences Inc. Breaks Below Key Support Level getLinesFromResByArray error: size == 0 - news-j.co.kr
How to read the order book for Artelo Biosciences Inc.2025 Major Catalysts & Entry Point Confirmation Signals - Newser
Artelo Biosciences Inc Azioni (ARTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):